Doug Kornbrust

Statistics

Publications

Citations

610

H-Index

Active since

1996

Affiliations

Ionis Pharmaceuticals (United States)(Current)

Doug Kornbrust is an author at Ionis Pharmaceuticals (United States) specializing in oligonucleotide chemistry, molecular pharmacology, and oligonucleotide therapeutics.

Publications per year

1996–2013

Publications

Pharmacokinetic properties of several novel oligonucleotide analogs in mice.

Stanley T. Crooke, Melissa Graham, J E Zuckerman et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 228 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

An ICAM-1 Antisense Oligonucleotide Prevents and Reverses Dextran Sulfate Sodium-Induced Colitis in Mice

C. Frank Bennett, Doug Kornbrust, Scott P. Henry et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 191 citations

Life Sciences, Immunology, Pathology +15

Pharmacokinetics of a potential human cytomegalovirus therapeutic, a phosphorothioate oligonucleotide, after intravitreal injection in the rabbit.

Janet M. Leeds, Scott P. Henry, L Truong et al. · PubMed · 1997 · 72 citations

Medicine, Ophthalmology, Pharmacokinetics +14

Oligo Safety Working Group Exaggerated Pharmacology Subcommittee Consensus Document

Doug Kornbrust, Joy Cavagnaro, Arthur A. Levin et al. · Nucleic Acid Therapeutics · 2013 · 45 citations

Medicine, Molecular Biology, Pharmacology +14

Pharmacokinetics in mice of a [3H]-labeled phosphorothioate oligonucleotide formulated in the presence and absence of a cationic lipid

C. Frank Bennett, J E Zuckerman, Doug Kornbrust et al. · Journal of Controlled Release · 1996 · 30 citations

Pharmacy, Pharmaceutics, Pharmacokinetics +12

1–5 of 7